Here, we showed that WOTS-418, a new HSV-tk418m armed VV-tk deleted OVV, has improved tumor selectivity, robust oncolytic capacity in multiple human solid tumors, and that GCV treatment is substantially potent in inhibition of undesirable viral replication (>10 fold) both in vitro and in vivo. This evidence concerns the gene TKT and neoplasm.